John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 67,956 shares at $170.36 ($11.7M) on 2021-11-12, disclosed to the SEC on 2021-11-12.
Open-market sale of $11.7M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $170.36 | 10,365 | $1.8M | 15.1% |
| 2 | $170.36 | 10,365 | $1.8M | 15.1% |
| 3 | $171.35 | 7,742 | $1.3M | 11.4% |
| 4 | $171.35 | 7,742 | $1.3M | 11.4% |
| 5 | $172.22 | 14,518 | $2.5M | 21.5% |
| 6 | $172.22 | 14,518 |
| $2.5M |
| 21.5% |
| 7 | $173.25 | 683 | $118K | 1.0% |
| 8 | $173.25 | 683 | $118K | 1.0% |
| 9 | $174.34 | 670 | $117K | 1.0% |
| 10 | $174.34 | 670 | $117K | 1.0% |
| Total | $171.52 avg | 67,956 | $11.7M | 100% |
| Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |
| ALNY | SELL | 2020-08-21 | $9.5M | — | Filing → |